Engineered smart biomaterials for gene delivery

Gene Therapy and Molecular Biology

Volumn 14, Issue 1, 2012, Pages 72-86

  Amini, R ^a,b   Hosseinkhani, H ^c   Abdulamir, A S ^d   Rosli, R ^a,b   Jalilian, F Azizi ^e  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d AL NAHRAIN UNIVERSITY   (Iraq)

^e ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ADENOVIRUS VECTOR; ANTIBODY; BIOMATERIAL; CATIONIC LIPID; CHOLESTEROL; CYTOKINE; DEXTRAN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; GROWTH FACTOR; HEXADIMETHRINE BROMIDE; LENTIVIRUS VECTOR; LIPID; LIPOPLEX; LIPOPOLYPLEX; LIPOSOME; MACROGOL; PARVOVIRUS VECTOR; POLYAMIDOAMINE; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; POLYSACCHARIDE; PROTEIN; RETROVIRUS VECTOR; RIBOZYME; RNA; SPERMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOENGINEERING; CELL FUNCTION; CELL REGENERATION; DNA MODIFICATION; DRUG INDUSTRY; FOOD INDUSTRY; GENE FUNCTION; GENE LOCATION; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC TRANSFECTION; HEALING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSECT; NONHUMAN; REVIEW; WEATHER;

HEXAPODA;

EID: 84865971301     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Allen, T., and Chonn, A. (1987). Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Letters, 223(1), 42-46.
2. Alton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., et al. (1999). Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. The Lancet, 353(9157), 947-954.
3. Anderson, W. (1998). Nature 392 Suppl.(1998). View Record in Scopus{pipe} Cited By in Scopus (643), 25-30.
4. Anwer, K., Kao, G., Proctor, B., Anscombe, I., Florack, V., Earls, R., et al. (2000). Ultrasound enhancement of cationic lipidmediated gene transfer to primary tumors following systemic administration. Gene Therapy, 7(21), 1833-1839.
5. Azzam, T., Eliyahu, H., Makovitzki, A., and Domb, A. (2003). Dextran spermine conjugate: an efficient vector for gene delivery.
6. Azzam, T., Raskin, A., Makovitzki, A., Brem, H., Vierling, P., Lineal, M., et al. (2002). Cationic polysaccharides for gene delivery. Macromolecules, 35(27), 9947-9953.
7. BANK, A., DORAZIO, R., and LEBOULCH, P. (2005). A Phase I/II Clinical Trial of Globin Gene Therapy for Thalassemia. Annals of the New York Academy of Sciences, 1054(1), 308-316.
8. Behr, J. (1997). The proton sponge: a trick to enter cells the viruses did not exploit. CHIMIA International Journal for Chemistry, 51, 1(2), 34-36.
9. Behr, J. P. (1994). Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconjugate Chemistry, 5(5), 382-389.
10. Berscht, P., Nies, B., Liebendörfer, A., and Kreuter, J. (1995). In vitro evaluation of biocompatibility of different wound dressing materials. Journal of Materials Science: Materials in Medicine, 6(4), 201-205.
11. Boussif, O., Lezoualc'h, F., Zanta, M., Mergny, M., Scherman, D., Demeneix, B., et al. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 92(16), 7297.
12. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., et al. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 92(16), 7297.
13. Brinster, R. L., Chen, H. Y., Trumbauer, M. E., Yagle, M. K., and Palmiter, R. D. (1985). Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proceedings of the National Academy of Sciences of the United States of America, 82(13), 4438.
14. Brown, M., Schätzlein, A., Brownlie, A., Jack, V., Wang, W., Tetley, L., et al. (2000). Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. Bioconjugate Chem, 11(6), 880-891.
15. Capecchi, M. R. (1980). High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell, 22(2), 479-488.
16. Carreño-Gómez, B., and Duncan, R. (1997). Evaluation of the biological properties of soluble chitosan and chitosan microspheres. International Journal of Pharmaceutics, 148(2), 231-240.
17. Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. S., Gross, F., Yvon, E., Nusbaum, P., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288(5466), 669.
18. Chamberlain, J. S. (2002). Gene therapy of muscular dystrophy. Human molecular genetics, 11(20), 2355.
19. Cho, K. C., Kim, S. H., Jeong, J. H., and Park, T. G. (2005). Folate receptor-mediated gene delivery using folate-poly (ethylene glycol)-poly (L-lysine) conjugate. Macromolecular bioscience, 5(6), 512-519.
20. Choosakoonkriang, S., Lobo, B. A., Koe, G. S., Koe, J. G., and Middaugh, C. R. (2003). Biophysical characterization of PEI/DNA complexes. Journal of Pharmaceutical Sciences, 92(8), 1710-1722.
21. Conary, J. T., Erdos, G., McGuire, M., Faulks, R., Gagne, L., Price, P., et al. (1996). Cationic liposome plasmid DNA complexes: in vitro cell entry and transgene expression augmented by synthetic signal peptides. European Journal of Pharmaceutics and Biopharmaceutics, 42(4), 277-285.
22. Corbel, S. Y., and Rossi, F. M. V. (2002). Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. [doi: DOI: 10.1016/S0958-1669(02)00361-0]. Current opinion in biotechnology, 13(5), 448-452.
23. Coukos, G., and Rubin, S. C. (1998). Chemotherapy resistance in ovarian cancer: new molecular perspectives. Obstetrics and Gynecology, 91(5 Part 1), 783.
24. Cullis, P. R., Hope, M. J., and Tilcock, C. P. S. (1986). Lipid polymorphism and the roles of lipids in membranes. Chemistry and physics of lipids, 40(2-4), 127-144.
25. Cusack, J. C., & Tanabe, K. K. (2002). Introduction to cancer gene therapy. DOI: 10.1016/S1055-3207(02)00029-7]. Surgical Oncology Clinics of North America, 11(3), 497-519
26. Dash, P., Read, M., Barrett, L., Wolfert, M., & Seymour, L. (1999). Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Therapy, 6(4), 643.
27. Deshane, J., Cabrera, G., Grim, J. E., Siegal, G. P., Pike, J., Alvarez, R. D., et al. (1995). Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Gynecologic Oncology, 59(1), 8-14.
28. Dowty, M. E., Williams, P., Zhang, G., Hagstrom, J. E., and Wolff, J. A. (1995). Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proceedings of the National Academy of Sciences of the United States of America, 92(10), 4572.
29. Dunlap, D., Maggi, A., Soria, M., and Monaco, L. (1997). Nanoscopic structure of DNA condensed for gene delivery. Nucleic acids research, 25(15), 3095.
30. Dwarki, V. J., Belloni, P., Nijjar, T., Smith, J., Couto, L., Rabier, M., et al. (1995). Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proceedings of the National Academy of Sciences of the United States of America, 92(4), 1023.
31. Eastman, S., Siegel, C., Tousignant, J., Smith, A., Cheng, S., and Scheule, R. (1997). Biophysical characterization of cationic lipid: DNA complexes. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1325(1), 41-62.
32. Escriou, V., Ciolina, C., Lacroix, F., Byk, G., Scherman, D., and Wils, P. (1998). Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1368(2), 276-288.
33. Farhood, H., Serbina, N., and Huang, L. (1995). The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1235(2), 289-295.
34. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., et al. (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America, 84(21), 7413.
35. Fielding, A. K., Chapel-Fernandes, S., Chadwick, M. P., Bullough, F. J., Cosset, F. L., and Russell, S. J. (2000). A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Human gene therapy, 11(6), 817-826.
36. Gao, H., and Hui, K. (2001). Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives. Gene Therapy, 8(11), 855.
37. Gao, X., and Huang, L. (1996). Potentiation of Cationic Liposome-Mediated Gene Delivery by Polycations†. Biochemistry, 35(3), 1027-1036.
38. Gersting, S. W., Schillinger, U., Lausier, J., Nicklaus, P., Rudolph, C., Plank, C., et al. (2004). Gene delivery to respiratory epithelial cells by magnetofection. The Journal of Gene Medicine, 6(8), 913-922.
39. Glover, D. J., Lipps, H. J., and Jans, D. A. (2005). Towards safe, non-viral therapeutic gene expression in humans. Nature Reviews Genetics, 6(4), 299-310.
40. Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., et al. (1996). -arrestin acts as a clathrin adaptor in endocytosis of the 2-adrenergic receptor.
41. Grabe, M., and Oster, G. (2001). Regulation of organelle acidity. The Journal of General Physiology, 117(4), 329.
42. Guo, W., and Lee, R. J. (2000). Efficient gene delivery using anionic liposome-complexed polyplexes (LPDII). Bioscience Reports, 20(5), 419-432.
43. Hagstrom, J. E., Ludtke, J. J., Bassik, M. C., Sebestyén, M. G., Adam, S. A., and Wolff, J. A. (1997). Nuclear import of DNA in digitonin-permeabilized cells. Journal of Cell Science, 110(18), 2323.
44. Hapala, I. (1997). Breaking the barrier: methods for reversible permeabilization of cellular membranes. Critical reviews in biotechnology, 17(2), 105-122.
45. Harrington, K., Spitzweg, C., Bateman, A., Morris, J., and Vile, R. (2001). Gene therapy for prostate cancer: current status and future prospects. The Journal of urology, 166(4), 1220-1233.
46. Harris, J., Gutierrez, A., Hurst, H., Sikora, K., and Lemoine, N. (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy, 1(3), 170.
47. Hart, S. (2000). Synthetic vectors for gene therapy. etp, 10(2), 199-208.
48. Hosseinkhani, H., Azzam, T., Tabata, Y., and Domb, A. (2004). Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection. Gene Therapy, 11(2), 194-203.
49. Hug, P., and Sleight, R. G. (1991). Liposomes for the transformation of eukaryotic cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1097(1), 1-17.
50. Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H., and Kitagawa, T. (2000). Characteristics and biodistribution of cationic liposomes and their DNA complexes. Journal of Controlled Release, 69(1), 139-148.
51. James, M. B., and Giorgio, T. D. (2000). Nuclear-associated plasmid, but not cell-associated plasmid, is correlated with transgene expression in cultured mammalian cells. Molecular Therapy, 1(4), 339-346.
52. Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., et al. (2004). Transferrin-Modified Liposomes Equipped with a pH-Sensitive Fusogenic Peptide: An Artificial Viral-like Delivery System†. Biochemistry, 43(19), 5618-5628.
53. Khalil, I. A., Kogure, K., Akita, H., and Harashima, H. (2006). Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacological reviews, 58(1), 32.
54. Kichler, A., Leborgne, C., Coeytaux, E., and Danos, O. (2001). Polyethylenimine-mediated gene delivery: a mechanistic study. The Journal of Gene Medicine, 3(2), 135-144.
55. Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K. H., Zauner, W., et al. (1999). Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. The Journal of Gene Medicine, 1(2), 111-120.
56. Kunath, K., Von Harpe, A., Fischer, D., Petersen, H., Bickel, U., Voigt, K., et al. (2003). Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecularweight polyethylenimine. Journal of Controlled Release, 89(1), 113-125.
57. Kwak, S. Y., Kriven, W. M., Wallig, M. A., and Choy, J. H. (2004). Inorganic delivery vector for intravenous injection. Biomaterials, 25(28), 5995-6001.
58. Labat-Moleur, F., Steffan, A., Brisson, C., Perron, H., Feugeas, O., Furstenberger, P., et al. (1996). An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Therapy, 3(11), 1010.
59. Larochelle, A., Vormoor, J., Lapidot, T., Sher, G., Furukawa, T., Li, Q., et al. (1995). Engraftment of immune-deficient mice with primitive hematopoietic cells from {beta}-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Human molecular genetics, 4(2), 163.
60. Lazennec, G., Alcorn, J. L., and Katzenellenbogen, B. S. (1999). Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Molecular Endocrinology, 13(6), 969.
61. Lechardeur, D., Sohn, K., Haardt, M., Joshi, P., Monck, M., Graham, R., et al. (1999). Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Therapy, 6(4), 482.
62. Lechardeur, D., Verkman, A., and Lukacs, G. L. (2005). Intracellular routing of plasmid DNA during non-viral gene transfer. Advanced Drug Delivery Reviews, 57(5), 755-767.
63. Lee, H., Jeong, J. H., and Park, T. G. (2002). PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. Journal of Controlled Release, 79(1-3), 283-291.
64. Lee, R., and Huang, L. (1996). Folate-targeted, anionic liposomeentrapped polylysine-condensed DNA for tumor cellspecific gene transfer. Journal of Biological Chemistry, 271(14), 8481.
65. Lee, R. J., and Huang, L. (1996). Folate-targeted, anionic liposomeentrapped polylysine-condensed DNA for tumor cellspecific gene transfer. Journal of Biological Chemistry, 271(14), 8481.
66. Leong, K., Mao, H., Truong-Le, V., Roy, K., Walsh, S., and August, J. (1998). DNA-polycation nanospheres as nonviral gene delivery vehicles. Journal of Controlled Release, 53(1-3), 183-193.
67. Leong, K. W., Mao, H. Q., Truong-Le, V. L., Roy, K., Walsh, S. M., and August, J. T. (1998). DNA-polycation nanospheres as non-viral gene delivery vehicles. [doi: DOI: 10.1016/S0168-3659(97)00252-6]. Journal of Controlled Release, 53(1-3), 183-193.
68. Li, S., and Ma, Z. (2001). Nonviral gene therapy. Current Gene Therapy, 1(2), 201-226.
69. Li, S., Rizzo, M., Bhattacharya, S., and Huang, L. (1998). Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Therapy, 5(7), 930.
70. Li, S., Tseng, W., Stolz, D. B., Wu, S., Watkins, S., and Huang, L. (1999). Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Therapy, 6(4), 585.
71. Liu, F., and Huang, L. (2002). Development of non-viral vectors for systemic gene delivery. [doi: DOI: 10.1016/S0168-3659(01)00494-1]. Journal of Controlled Release, 78(1-3), 259-266.
72. Liu, Y., Mounkes, L. C., Liggitt, H. D., Brown, C. S., Solodin, I., Heath, T. D., et al. (1997). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature biotechnology, 15(2), 167-173.
73. Lu, Y., Carraher, J., Zhang, Y., Armstrong, J., Lerner, J., Rogers, W. P., et al. (1999). Delivery of adenoviral vectors to the prostate for gene therapy. Cancer Gene Therapy, 6(1), 64.
74. Ludtke, J. J., Zhang, G., Sebestyén, M. G., and Wolff, J. A. (1999). A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. Journal of Cell Science, 112, 2033.
75. Mattaj, I. W., and Englmeier, L. (1998). Nucleocytoplasmic transport: the soluble phase. Annual review of biochemistry, 67, 265.
76. Maxfield, F., and Yamashiro, D. (1987). Endosome acidification and the pathways of receptor-mediated endocytosis. Advances in experimental medicine and biology, 225, 189.
77. Mirzayans, R., Aubin, R. A., and Paterson, M. C. (1992). Differential expression and stability of foreign genes introduced into human fibroblasts by nuclear versus cytoplasmic microinjection. Mutation Research Letters, 281(2), 115-122.
78. Mohanraj, V., and Chen, Y. (2007). Nanoparticles-A review. Tropical Journal of Pharmaceutical Research, 5(1), 561.
79. Moisset, P.-A., and Tremblay, J. P. (2001). Gene therapy: a strategy for the treatment of inherited muscle diseases? [doi: DOI: 10.1016/S1471-4892(01)00052-2]. Current Opinion in Pharmacology, 1(3), 294-299.
80. Mumper, R., Duguid, J., Anwer, K., Barron, M., Nitta, H., and Rolland, A. (1996). Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharmaceutical research, 13(5), 701-709.
81. Niidome, T., and Huang, L. (2002). Gene therapy progress and prospects: nonviral vectors. Gene Therapy, 9(24), 1647-1652.
82. Nishikawa, M., and Huang, L. (2001). Nonviral vectors in the new millennium: delivery barriers in gene transfer. Human gene therapy, 12(8), 861-870.
83. Obermiller, P. S., Tait, D. L., and Holt, J. T. (1999). Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Res, 2(1), 28.
84. Oupicky, D., Ogris, M., Howard, K. A., Dash, P. R., Ulbrich, K., and Seymour, L. W. (2002). Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Molecular Therapy, 5(4), 463-472.
85. Pante, N., and Kann, M. (2002). Nuclear pore complex is able to transport macromolecules with diameters of~ 39 nm. Molecular biology of the cell, 13(2), 425.
86. Perales, J. C., Grossmann, G. A., Molas, M., Liu, G., Ferkol, T., Harpst, J., et al. (1997). Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. Journal of Biological Chemistry, 272(11), 7398.
87. Plank, C., Mechtler, K., Szoka Jr, F. C., and Wagner, E. (1996). Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Human gene therapy, 7(12), 1437-1446.
88. Plank, C., Zauner, W., and Wagner, E. (1998). Application of membrane-active peptides for drug and gene delivery across cellular membranes. Advanced Drug Delivery Reviews, 34(1), 21-35.
89. Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., Di Tomaso, E., et al. (2001). Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4628.
90. Pollard, H., Remy, J. S., Loussouarn, G., Demolombe, S., Behr, J. P., and Escande, D. (1998). Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. Journal of Biological Chemistry, 273(13), 7507.
91. Putnam, D., Gentry, C., Pack, D., and Langer, R. (2001). Polymerbased gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proceedings of the National Academy of Sciences of the United States of America, 98(3), 1200.
92. Radwan Almofti, M., Harashima, H., Shinohara, Y., Almofti, A., Baba, Y., and Kiwada, H. (2003). Cationic liposomemediated gene delivery: biophysical study and mechanism of internalization. Archives of biochemistry and biophysics, 410(2), 246-253.
93. Remy, J., Abdallah, B., Zanta, M., Boussif, O., Behr, J., and Demeneix, B. (1998). Gene transfer with lipospermines and polyethylenimines. Advanced Drug Delivery Reviews, 30(1-3), 85-95.
94. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., and Henderson, D. R. (1997). Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigenpositive prostate cancer cells. Cancer Research, 57(13), 2559.
95. Rolland, A. P. (1998). From genes to gene medicines: recent advances in nonviral gene delivery. Critical reviews in therapeutic drug carrier systems, 15(2), 143.
96. Rosenberg, S. A. (2001). Progress in human tumour immunology and immunotherapy. nature, 411(6835), 380-384.
97. Roy, K., Mao, H. Q., Huang, S. K., and Leong, K. W. (1999). Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature medicine, 5(4), 387.
98. Schmidt-Wolf, G. D. S.-W. I. G. H. (2003). Gene therapy for hematological malignancies. Clin Exp Med.
99. Shewring, L., Collins, L., Lightman, S. L., Hart, S., Gustafsson, K., and Fabre, J. W. (1997). A Nonviral Vector System for Efficient Gene Transfer To Corneal Endothelial Cells Via Membrane Integrins 1. Transplantation, 64(5), 763.
100. Sosnowski, B., Gonzalez, A., Chandler, L., Buechler, Y., Pierce, G., and Baird, A. (1996). Targeting DNA to cells with basic fibroblast growth factor (FGF2). Journal of Biological Chemistry, 271(52), 33647.
101. Tang, M. X., Redemann, C. T., and Szoka Jr, F. C. (1996). In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem, 7(6), 703-714.
102. Tseng, W. C., and Jong, C. M. (2003). Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules, 4(5), 1277-1284.
103. Wagner, E., Plank, C., Zatloukal, K., Cotten, M., and Birnstiel, M. L. (1992). Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrinpolylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proceedings of the National Academy of Sciences of the United States of America, 89(17), 7934.
104. Ward, C. M., Pechar, M., Oupicky, D., Ulbrich, K., and Seymour, L. W. (2002). Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate mediated targeting in vitro and prolonged plasma circulation in vivo. The Journal of Gene Medicine, 4(5), 536-547.
105. Ward, C. M., Read, M. L., and Seymour, L. W. (2001). Systemic circulation of poly (L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood, 97(8), 2221.
106. Wasan, E. K., Reimer, D. L., and Bally, M. B. (1996). Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. Journal of Pharmaceutical Sciences, 85(4), 427-433.
107. Whitmore, M. M. C. (2000). Antitumor activity of the LPD lipopolyplex prepared with immunostimulatory CpG DNA: University of Pittsburgh.
108. Wiethoff, C., and Middaugh, C. (2003). Barriers to nonviral gene delivery. Journal of Pharmaceutical Sciences, 92(2), 203-217.
109. Wiethoff, C. M., and Middaugh, C. R. (2003). Barriers to nonviral gene delivery. Journal of Pharmaceutical Sciences, 92(2), 203-217.
110. Wilson, G. L., Dean, B. S., Wang, G., and Dean, D. A. (1999). Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and specific DNA sequences. Journal of Biological Chemistry, 274(31), 22025.
111. Wu, G., and Wu, C. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. Journal of Biological Chemistry, 262(10), 4429.
112. Wu, G. Y., and Wu, C. H. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. Journal of Biological Chemistry, 262(10), 4429.
113. Xus, Y., and Szoka Jr, F. C. (1996). Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection†,‡. Biochemistry, 35(18), 5616-5623.
114. Yamashiro, D. J., Fluss, S. R., and Maxfield, F. R. (1983). Acidification of endocytic vesicles by an ATP-dependent proton pump. The Journal of cell biology, 97(3), 929.
115. Yi, S. W., Yune, T. Y., Kim, T. W., Chung, H., Choi, Y. W., Kwon, I. C., et al. (2000). A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharmaceutical research, 17(3), 314-320.
116. Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., and Welsh, M. J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. Journal of Biological Chemistry, 270(32), 18997.
117. Zanta, M. A., Belguise-Valladier, P., and Behr, J. P. (1999). Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proceedings of the National Academy of Sciences of the United States of America, 96(1), 91.
118. Zelphati, O., and Szoka, F. C. (1996). Mechanism of oligonucleotide release from cationic liposomes. Proceedings of the National Academy of Sciences of the United States of America, 93(21), 11493.
119. Zhang, Z. Y., and Smith, B. D. (2000). High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjugate Chem, 11(6), 805-814.
120. Zuhorn, I. S., Kalicharan, R., and Hoekstra, D. (2002). Lipoplexmediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. Journal of Biological Chemistry, 277(20), 18021.